Sharifi N - Search Results

1

HSD3B1 status as a biomarker of androgen deprivation resistance and implications for prostate cancer.

Hettel D, Sharifi N. Hettel D, et al. Among authors: sharifi n. Nat Rev Urol. 2018 Mar;15(3):191-196. doi: 10.1038/nrurol.2017.201. Epub 2017 Dec 12. Nat Rev Urol. 2018. PMID: 29231195 Review.

2

Androgen deprivation therapy for prostate cancer.

Sharifi N, Gulley JL, Dahut WL. Sharifi N, et al. JAMA. 2005 Jul 13;294(2):238-44. doi: 10.1001/jama.294.2.238. JAMA. 2005. PMID: 16014598 Review.

3

Prostate cancer-from steroid transformations to clinical translation.

Chang KH, Sharifi N. Chang KH, et al. Among authors: sharifi n. Nat Rev Urol. 2012 Dec;9(12):721-4. doi: 10.1038/nrurol.2012.175. Epub 2012 Oct 2. Nat Rev Urol. 2012. PMID: 23027067

4

Minireview: Androgen metabolism in castration-resistant prostate cancer.

Sharifi N. Sharifi N. Mol Endocrinol. 2013 May;27(5):708-14. doi: 10.1210/me.2013-1007. Epub 2013 Apr 16. Mol Endocrinol. 2013. PMID: 23592429 Free PMC article. Review.

5

Mechanisms of androgen receptor activation in castration-resistant prostate cancer.

Sharifi N. Sharifi N. Endocrinology. 2013 Nov;154(11):4010-7. doi: 10.1210/en.2013-1466. Epub 2013 Sep 3. Endocrinology. 2013. PMID: 24002034 Free PMC article. Review.

6

Androgen metabolism in prostate cancer: from molecular mechanisms to clinical consequences.

Chang KH, Ercole CE, Sharifi N. Chang KH, et al. Among authors: sharifi n. Br J Cancer. 2014 Sep 23;111(7):1249-54. doi: 10.1038/bjc.2014.268. Epub 2014 May 27. Br J Cancer. 2014. PMID: 24867689 Free PMC article. Review.

7

Androstenedione is the preferred androgen source in hormone refractory prostate cancer--letter.

Sharifi N, Auchus RJ. Sharifi N, et al. Clin Cancer Res. 2014 Sep 15;20(18):4971. doi: 10.1158/1078-0432.CCR-14-1123. Clin Cancer Res. 2014. PMID: 25225065 No abstract available.

8

Steroid sidestep: evading androgen ablation by abiraterone.

Sharifi N. Sharifi N. Clin Cancer Res. 2015 Mar 15;21(6):1240-2. doi: 10.1158/1078-0432.CCR-14-2899. Epub 2014 Nov 28. Clin Cancer Res. 2015. PMID: 25432158 Free PMC article.

9

Prostate cancer: CYP17A1 inhibitor failure-lessons for future drug development.

Sharifi N. Sharifi N. Nat Rev Urol. 2015 May;12(5):245-6. doi: 10.1038/nrurol.2015.66. Epub 2015 Mar 31. Nat Rev Urol. 2015. PMID: 25823374 No abstract available.

10

Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer.

Li Z, Bishop AC, Alyamani M, Garcia JA, Dreicer R, Bunch D, Liu J, Upadhyay SK, Auchus RJ, Sharifi N. Li Z, et al. Among authors: sharifi n. Nature. 2015 Jul 16;523(7560):347-51. doi: 10.1038/nature14406. Epub 2015 Jun 1. Nature. 2015. PMID: 26030522 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

372 results

Search Page

Filters